Kerry Lewis Bloomingdale, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognition Disorders | 2 | 2017 | 4043 | 0.230 |
Why?
|
| Dementia | 1 | 2017 | 2518 | 0.220 |
Why?
|
| Bipolar Disorder | 4 | 2017 | 5027 | 0.180 |
Why?
|
| Electroconvulsive Therapy | 5 | 2008 | 477 | 0.170 |
Why?
|
| Depressive Disorder | 9 | 2008 | 3748 | 0.150 |
Why?
|
| Fatigue Syndrome, Chronic | 2 | 2005 | 214 | 0.100 |
Why?
|
| Transcranial Magnetic Stimulation | 2 | 2015 | 1432 | 0.090 |
Why?
|
| Gastric Dilatation | 1 | 1988 | 4 | 0.090 |
Why?
|
| Amnesia, Retrograde | 1 | 2008 | 20 | 0.080 |
Why?
|
| Amnesia, Anterograde | 1 | 2008 | 21 | 0.080 |
Why?
|
| Pneumonia, Aspiration | 1 | 1988 | 145 | 0.080 |
Why?
|
| Gastric Emptying | 1 | 1988 | 233 | 0.070 |
Why?
|
| Monoamine Oxidase | 1 | 1986 | 178 | 0.070 |
Why?
|
| Lymphocyte Subsets | 1 | 2005 | 315 | 0.060 |
Why?
|
| Psychiatry | 2 | 2015 | 1695 | 0.060 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 3843 | 0.050 |
Why?
|
| Dexamethasone | 1 | 1986 | 1951 | 0.040 |
Why?
|
| Multiple Sclerosis | 2 | 2005 | 3079 | 0.040 |
Why?
|
| Norepinephrine | 2 | 1992 | 909 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 1986 | 1826 | 0.040 |
Why?
|
| Evoked Potentials, Visual | 2 | 1992 | 427 | 0.040 |
Why?
|
| Depressive Disorder, Major | 2 | 2005 | 4644 | 0.040 |
Why?
|
| Arousal | 2 | 1992 | 1165 | 0.030 |
Why?
|
| Affect | 1 | 2003 | 1476 | 0.030 |
Why?
|
| Blood Platelets | 1 | 1986 | 2508 | 0.030 |
Why?
|
| Methoxyhydroxyphenylglycol | 2 | 1992 | 93 | 0.030 |
Why?
|
| Memory | 1 | 2003 | 2174 | 0.030 |
Why?
|
| Seasonal Affective Disorder | 1 | 1992 | 50 | 0.030 |
Why?
|
| Middle Aged | 9 | 2017 | 213383 | 0.020 |
Why?
|
| Glycols | 1 | 1989 | 59 | 0.020 |
Why?
|
| Phototherapy | 1 | 1992 | 377 | 0.020 |
Why?
|
| Male | 10 | 2017 | 350118 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1992 | 1107 | 0.020 |
Why?
|
| Community Mental Health Centers | 1 | 1987 | 102 | 0.020 |
Why?
|
| Association Learning | 1 | 2008 | 224 | 0.020 |
Why?
|
| Clinical Enzyme Tests | 1 | 1986 | 115 | 0.020 |
Why?
|
| Epinephrine | 1 | 1989 | 792 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 1992 | 1670 | 0.020 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2005 | 246 | 0.010 |
Why?
|
| Humans | 14 | 2017 | 744343 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2005 | 793 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 1992 | 2731 | 0.010 |
Why?
|
| Mental Recall | 1 | 2008 | 1205 | 0.010 |
Why?
|
| Vanilmandelic Acid | 2 | 1992 | 17 | 0.010 |
Why?
|
| Normetanephrine | 2 | 1992 | 26 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2008 | 6365 | 0.010 |
Why?
|
| Neuropsychological Tests | 2 | 2003 | 6993 | 0.010 |
Why?
|
| Female | 12 | 2015 | 380194 | 0.010 |
Why?
|
| Electroencephalography | 2 | 1992 | 6150 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2005 | 1838 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2005 | 2133 | 0.010 |
Why?
|
| Adult | 7 | 2008 | 214055 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 1987 | 3528 | 0.010 |
Why?
|
| Technetium Tc 99m Exametazime | 1 | 1992 | 68 | 0.010 |
Why?
|
| Organotechnetium Compounds | 1 | 1992 | 137 | 0.010 |
Why?
|
| Oximes | 1 | 1992 | 311 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 21746 | 0.010 |
Why?
|
| Personality Inventory | 1 | 1992 | 1030 | 0.010 |
Why?
|
| Metanephrine | 1 | 1989 | 26 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 1989 | 635 | 0.000 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1989 | 525 | 0.000 |
Why?
|
| Prognosis | 1 | 1986 | 29063 | 0.000 |
Why?
|
| Aged | 5 | 1992 | 163280 | 0.000 |
Why?
|
| Photic Stimulation | 1 | 1992 | 2025 | 0.000 |
Why?
|
| Brain Mapping | 2 | 1992 | 6669 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2008 | 53288 | 0.000 |
Why?
|
| Brain | 1 | 1989 | 26385 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2003 | 23338 | 0.000 |
Why?
|
| Risk Factors | 1 | 1988 | 72290 | 0.000 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1989 | 1534 | 0.000 |
Why?
|
| Visual Cortex | 1 | 1989 | 1149 | 0.000 |
Why?
|
| Pilot Projects | 1 | 1992 | 8324 | 0.000 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1989 | 6038 | 0.000 |
Why?
|
| Psychotherapy | 1 | 1987 | 1643 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2003 | 63114 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 1992 | 5708 | 0.000 |
Why?
|
| Aged, 80 and over | 2 | 1992 | 57776 | 0.000 |
Why?
|
| Sex Factors | 1 | 1989 | 10397 | 0.000 |
Why?
|
| Antidepressive Agents | 1 | 1987 | 2838 | 0.000 |
Why?
|
| Psychotic Disorders | 1 | 1989 | 3046 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1989 | 12959 | 0.000 |
Why?
|
| Antipsychotic Agents | 1 | 1987 | 3057 | 0.000 |
Why?
|
| Age Factors | 1 | 1989 | 18370 | 0.000 |
Why?
|
| Adolescent | 2 | 1989 | 85781 | 0.000 |
Why?
|
| Algorithms | 1 | 1989 | 13881 | 0.000 |
Why?
|
| Mental Disorders | 1 | 1987 | 6600 | 0.000 |
Why?
|